Alkermes Plc Net Income
| ALKS Stock | USD 33.16 0.13 0.39% |
As of the 14th of February 2026, Alkermes Plc shows the Risk Adjusted Performance of 0.0239, downside deviation of 2.28, and Mean Deviation of 1.65. Alkermes Plc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Alkermes Plc information ratio, as well as the relationship between the potential upside and kurtosis to decide if Alkermes Plc is priced correctly, providing market reflects its regular price of 33.16 per share. Given that Alkermes Plc has jensen alpha of (0.04), we suggest you to validate Alkermes Plc's prevailing market performance to make sure the company can sustain itself at a future point.
Alkermes Plc Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.9309 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 422.1 M | 443.2 M | |
| Net Loss | -142.4 M | -135.3 M | |
| Net Income From Continuing Ops | 428 M | 449.4 M | |
| Net Income Per Share | 2.00 | 2.10 | |
| Net Income Per E B T | 0.74 | 0.92 |
Alkermes | Net Income | Build AI portfolio with Alkermes Stock |
The evolution of Net Income for Alkermes Plc provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Alkermes Plc compares to historical norms and industry peers.
Latest Alkermes Plc's Net Income Growth Pattern
Below is the plot of the Net Income of Alkermes Plc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Alkermes Plc financial statement analysis. It represents the amount of money remaining after all of Alkermes Plc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Alkermes Plc's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alkermes Plc's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 367.07 M | 10 Years Trend |
|
Net Income |
| Timeline |
Alkermes Net Income Regression Statistics
| Arithmetic Mean | 19,930,560 | |
| Geometric Mean | 110,667,138 | |
| Coefficient Of Variation | 1,157 | |
| Mean Deviation | 178,656,137 | |
| Median | (40,100,000) | |
| Standard Deviation | 230,623,870 | |
| Sample Variance | 53187.4T | |
| Range | 670.4M | |
| R-Value | 0.57 | |
| Mean Square Error | 38475.1T | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 25,908,541 | |
| Total Sum of Squares | 850997.9T |
Alkermes Net Income History
Other Fundumenentals of Alkermes Plc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Alkermes Plc Net Income component correlations
Alkermes Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Alkermes Plc is extremely important. It helps to project a fair market value of Alkermes Stock properly, considering its historical fundamentals such as Net Income. Since Alkermes Plc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Alkermes Plc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Alkermes Plc's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will Alkermes introduce new products? Factors like these will boost the valuation of Alkermes Plc. If investors know Alkermes will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Alkermes Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Earnings Share 2.01 | Revenue Per Share | Quarterly Revenue Growth 0.042 | Return On Assets |
Investors evaluate Alkermes Plc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Alkermes Plc's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Alkermes Plc's market price to deviate significantly from intrinsic value.
Understanding that Alkermes Plc's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alkermes Plc represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Alkermes Plc's market price signifies the transaction level at which participants voluntarily complete trades.
Alkermes Plc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alkermes Plc's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alkermes Plc.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Alkermes Plc on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Alkermes Plc or generate 0.0% return on investment in Alkermes Plc over 90 days. Alkermes Plc is related to or competes with PTC Therapeutics, Arcellx, Protagonist Therapeutics, ACADIA Pharmaceuticals, TG Therapeutics, Arrowhead Pharmaceuticals, and Vaxcyte. Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address u... More
Alkermes Plc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alkermes Plc's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alkermes Plc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.28 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 11.25 | |||
| Value At Risk | (3.30) | |||
| Potential Upside | 3.55 |
Alkermes Plc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alkermes Plc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alkermes Plc's standard deviation. In reality, there are many statistical measures that can use Alkermes Plc historical prices to predict the future Alkermes Plc's volatility.| Risk Adjusted Performance | 0.0239 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0301 |
Alkermes Plc February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0239 | |||
| Market Risk Adjusted Performance | 0.0401 | |||
| Mean Deviation | 1.65 | |||
| Semi Deviation | 2.24 | |||
| Downside Deviation | 2.28 | |||
| Coefficient Of Variation | 4632.93 | |||
| Standard Deviation | 2.3 | |||
| Variance | 5.27 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0301 | |||
| Maximum Drawdown | 11.25 | |||
| Value At Risk | (3.30) | |||
| Potential Upside | 3.55 | |||
| Downside Variance | 5.21 | |||
| Semi Variance | 5.0 | |||
| Expected Short fall | (1.80) | |||
| Skewness | (0.25) | |||
| Kurtosis | 1.95 |
Alkermes Plc Backtested Returns
Alkermes Plc appears to be very steady, given 3 months investment horizon. Alkermes Plc secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Alkermes Plc, which you can use to evaluate the volatility of the firm. Please makes use of Alkermes Plc's Mean Deviation of 1.65, risk adjusted performance of 0.0239, and Downside Deviation of 2.28 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Alkermes Plc holds a performance score of 8. The firm shows a Beta (market volatility) of 1.31, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Alkermes Plc will likely underperform. Please check Alkermes Plc's potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Alkermes Plc's price patterns will revert.
Auto-correlation | -0.45 |
Modest reverse predictability
Alkermes Plc has modest reverse predictability. Overlapping area represents the amount of predictability between Alkermes Plc time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alkermes Plc price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Alkermes Plc price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 5.66 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Alkermes Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Alkermes Plc reported net income of 367.07 M. This is 7.56% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 35.71% higher than that of the company.
Alkermes Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alkermes Plc's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alkermes Plc could also be used in its relative valuation, which is a method of valuing Alkermes Plc by comparing valuation metrics of similar companies.Alkermes Plc is currently under evaluation in net income category among its peers.
Alkermes Plc ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alkermes Plc's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alkermes Plc's managers, analysts, and investors.Environmental | Governance | Social |
Alkermes Plc Institutional Holders
Institutional Holdings refers to the ownership stake in Alkermes Plc that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Alkermes Plc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Alkermes Plc's value.| Shares | Primecap Management Company | 2025-06-30 | 2.9 M | Venbio Select Advisor Llc | 2025-06-30 | 2.9 M | Holocene Advisors, Lp | 2025-06-30 | 2.9 M | Commodore Capital Lp | 2025-06-30 | 2.5 M | Bank Of America Corp | 2025-06-30 | 2.2 M | Loomis, Sayles & Company Lp | 2025-06-30 | 2.1 M | Charles Schwab Investment Management Inc | 2025-06-30 | 2.1 M | Nuveen, Llc | 2025-06-30 | 2 M | Norges Bank | 2025-06-30 | 1.9 M | Blackrock Inc | 2025-06-30 | 27.9 M | Vanguard Group Inc | 2025-06-30 | 18.5 M |
Alkermes Fundamentals
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0999 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 4.46 B | ||||
| Shares Outstanding | 165.12 M | ||||
| Shares Owned By Insiders | 1.57 % | ||||
| Shares Owned By Institutions | 98.43 % | ||||
| Number Of Shares Shorted | 19 M | ||||
| Price To Earning | (38.45) X | ||||
| Price To Book | 3.17 X | ||||
| Price To Sales | 3.60 X | ||||
| Revenue | 1.56 B | ||||
| Gross Profit | 1.31 B | ||||
| EBITDA | 494.86 M | ||||
| Net Income | 367.07 M | ||||
| Cash And Equivalents | 580.97 M | ||||
| Cash Per Share | 3.54 X | ||||
| Total Debt | 75.54 M | ||||
| Debt To Equity | 0.38 % | ||||
| Current Ratio | 2.38 X | ||||
| Book Value Per Share | 10.50 X | ||||
| Cash Flow From Operations | 439.12 M | ||||
| Short Ratio | 8.72 X | ||||
| Earnings Per Share | 2.01 X | ||||
| Price To Earnings To Growth | (1,057) X | ||||
| Target Price | 43.81 | ||||
| Number Of Employees | 1.8 K | ||||
| Beta | 0.46 | ||||
| Market Capitalization | 5.48 B | ||||
| Total Asset | 2.06 B | ||||
| Retained Earnings | (976.46 M) | ||||
| Working Capital | 950.16 M | ||||
| Current Asset | 754.96 M | ||||
| Current Liabilities | 236.21 M | ||||
| Net Asset | 2.06 B |
About Alkermes Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alkermes Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alkermes Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alkermes Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alkermes Stock Analysis
When running Alkermes Plc's price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.